Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback